Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis
References (26)
- et al.
Usefulness of the electrocardiogram and echocardiogram in predicting the amount of interstitial myocardial collagen in endomyocardial biopsy specimens of patients with chronic heart failure
Am J Cardiol
(1992) - et al.
Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis: relationship to liver histology and conventional liver tests
J Hepatol
(1991) - et al.
Enhanced deposition of predominantly type I collagen in myocardial diseases
J Mol Cell Cardiol
(1990) - et al.
Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy
Circulation
(1985) - et al.
In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans
Circulation
(1990) - et al.
The extracellular matrix in the human failing heart
Basic Res Cardiol
(1992) - et al.
Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy
Circulation
(1991) - et al.
Increased serum concentration of type-I procollagen C-terminal propeptide and osteocalcin during short course of calcitriol administration to adult male volunteers
Acta Endocrinol
(1991) - et al.
Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders
Clin Rheumatol
(1988) - et al.
N-terminal propeptide of type-III collagen in tracheal fluid and serum in preterm infants at risk for bronchopulmonary dysplasia
Pediatr Res
(1992)
Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lung of patients with idiopathic pulmonary fibrosis
Am Rev Respir Dis
(1988)
Serum procollagen III peptide levels in subjects with sarcoidosis
Am Rev Respir Dis
(1992)
Determination of serum concentrations of type III procollagen peptide in mechanically ventilated patients. Pronounced augmented concentrations in the adult respiratory distress syndrome
Am Rev Respir Dis
(1990)
Cited by (233)
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
2023, Molecular Aspects of MedicineChimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
2022, Journal of Biological ChemistryMyocardial fibrosis: morphologic patterns and role of imaging in diagnosis and prognostication
2022, Cardiovascular PathologyTraditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms
2021, Biomedicine and PharmacotherapyQuantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference
2021, Diagnostic and Interventional ImagingCitation Excerpt :The cardiac expression of TIMP-1 and TIMP-2 is significantly increased in chronic pressure-overloaded cardiopathy compared with controls and is related to the degree of interstitial fibrosis [7]. Nevertheless, propeptide of procollagen that correlates with histologic CVF [9,10], correlates with excentric and concentric cardiac remodeling in our study. Myocardial fibrosis increases ventricular stiffness and leads to diastolic dysfunction.
Advances in bone turnover markers
2021, Advances in Clinical Chemistry
This study was supported mainly by Grant 9357-MED from the Fonds zur Fo¨rderung der wissenschaftlichen Forschung, and in part by Grant 4432 from the Anton-Dreher-Geda¨chtnisschenkung and Grant 193/ 91 from the Jubila¨umsfonds derO¨sterreichischen Nationalbank, Vienna, Austria.
Copyright © 1995 Published by Elsevier Inc.